BMJ Group: Oral Menopausal Hormone Therapy Linked to Higher Blood Clot Risk in Legs or Lungs Regardless of Dose or Duration
September 25, 2026
September 25, 2026
LONDON, England, Sept. 25 (TNSjou) -- BMJ Group issued the following news release:
* * *
Oral menopausal hormone therapy linked to higher blood clot risk in legs or lungs regardless of dose or duration
But stroke and heart attack risks limited to prolonged high-dose therapy, and no general increased risk seen with transdermal hormone therapy, findings show
-
Current use of oral menopausal hormone therapy (commonly known as hormone . . .
* * *
Oral menopausal hormone therapy linked to higher blood clot risk in legs or lungs regardless of dose or duration
But stroke and heart attack risks limited to prolonged high-dose therapy, and no general increased risk seen with transdermal hormone therapy, findings show
-
Current use of oral menopausal hormone therapy (commonly known as hormone . . .